Case reports of unexplained weight loss in autoimmune central neurological syndromes with anti-GAD antibodies

James Broadley, Mastura Monif

Research output: Contribution to journalArticleOtherpeer-review

Abstract

Glutamic acid decarboxylase (GAD) is becoming increasingly recognised as an antigenic target in autoimmune disorders of the central nervous system. There are currently no reports of weight loss being a manifestation in such disorders. We describe two cases of anti-GAD associated neurological disorders with profound and otherwise unexplained weight loss. Both patients had incomplete response to immunotherapy, as is becoming typical of these disorders. The variable disease associations of anti-GAD antibodies is incompletely understood, and leads us to question whether weight loss in these patients could possibly be immune-mediated.
Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalCase reports in internal medicine
Volume6
Issue number2
DOIs
Publication statusPublished - 24 Jan 2019

Cite this

@article{aa7c3b3234764972ac272e1416dd7127,
title = "Case reports of unexplained weight loss in autoimmune central neurological syndromes with anti-GAD antibodies",
abstract = "Glutamic acid decarboxylase (GAD) is becoming increasingly recognised as an antigenic target in autoimmune disorders of the central nervous system. There are currently no reports of weight loss being a manifestation in such disorders. We describe two cases of anti-GAD associated neurological disorders with profound and otherwise unexplained weight loss. Both patients had incomplete response to immunotherapy, as is becoming typical of these disorders. The variable disease associations of anti-GAD antibodies is incompletely understood, and leads us to question whether weight loss in these patients could possibly be immune-mediated.",
author = "James Broadley and Mastura Monif",
year = "2019",
month = "1",
day = "24",
doi = "10.5430/crim.v6n2p5",
language = "English",
volume = "6",
pages = "1--6",
journal = "Case reports in internal medicine",
issn = "2332-7251",
number = "2",

}

Case reports of unexplained weight loss in autoimmune central neurological syndromes with anti-GAD antibodies. / Broadley, James; Monif, Mastura.

In: Case reports in internal medicine , Vol. 6, No. 2, 24.01.2019, p. 1-6.

Research output: Contribution to journalArticleOtherpeer-review

TY - JOUR

T1 - Case reports of unexplained weight loss in autoimmune central neurological syndromes with anti-GAD antibodies

AU - Broadley, James

AU - Monif, Mastura

PY - 2019/1/24

Y1 - 2019/1/24

N2 - Glutamic acid decarboxylase (GAD) is becoming increasingly recognised as an antigenic target in autoimmune disorders of the central nervous system. There are currently no reports of weight loss being a manifestation in such disorders. We describe two cases of anti-GAD associated neurological disorders with profound and otherwise unexplained weight loss. Both patients had incomplete response to immunotherapy, as is becoming typical of these disorders. The variable disease associations of anti-GAD antibodies is incompletely understood, and leads us to question whether weight loss in these patients could possibly be immune-mediated.

AB - Glutamic acid decarboxylase (GAD) is becoming increasingly recognised as an antigenic target in autoimmune disorders of the central nervous system. There are currently no reports of weight loss being a manifestation in such disorders. We describe two cases of anti-GAD associated neurological disorders with profound and otherwise unexplained weight loss. Both patients had incomplete response to immunotherapy, as is becoming typical of these disorders. The variable disease associations of anti-GAD antibodies is incompletely understood, and leads us to question whether weight loss in these patients could possibly be immune-mediated.

U2 - 10.5430/crim.v6n2p5

DO - 10.5430/crim.v6n2p5

M3 - Article

VL - 6

SP - 1

EP - 6

JO - Case reports in internal medicine

JF - Case reports in internal medicine

SN - 2332-7251

IS - 2

ER -